A2 Refereed review article in a scientific journal
Consensus statement on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: Localized scleroderma, systemic sclerosis and overlap syndromes
Authors: Knobler, Robert; Geroldinger-Simic, Marija; Kreuter, Alexander; Hunzelmann, Nicolas; Moinzadeh, Pia; Rongioletti, Franco; Denton, Christopher; Mouthon, Luc; Cutolo, Maurizio; Smith, Vanessa; Gabrielli, Armando; Bagot, Martine; Olesen, Anne B.; Foeldvari, Ivan; Jalili, Ahmad; Kähäri, Veli-Matti; Karpati, Sarolta; Kofoed, Kristian; Olszewska, Malgorzata; Panelius, Jaana; Quaglino, Pietro; Seneschal, Julien; Sticherling, Michael; Sunderkotter, Cord; Tanew, Adrian; Wolf, Peter; Worm, Margitta; Skrok, Anna; Rudnicka, Lidia; Krieg, Thomas
Publisher: Wiley-Blackwell
Publication year: 2024
Journal: Journal of the European Academy of Dermatology and Venereology
Journal name in source: JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
Volume: 38
Issue: 7
First page : 1251
Last page: 1280
ISSN: 0926-9959
eISSN: 1468-3083
DOI: https://doi.org/10.1111/jdv.19912
Publication's open availability at the time of reporting: No Open Access
Publication channel's open availability : Partially Open Access publication channel
Web address : https://doi.org/10.1111/jdv.19912
The term 'sclerosing diseases of the skin' comprises specific dermatological entities, which have fibrotic changes of the skin in common. These diseases mostly manifest in different clinical subtypes according to cutaneous and extracutaneous involvement and can sometimes be difficult to distinguish from each other. The present consensus provides an update to the 2017 European Dermatology Forum Guidelines, focusing on characteristic clinical and histopathological features, diagnostic scores and the serum autoantibodies most useful for differential diagnosis. In addition, updated strategies for the first- and advanced-line therapy of sclerosing skin diseases are addressed in detail. Part 1 of this consensus provides clinicians with an overview of the diagnosis and treatment of localized scleroderma (morphea), and systemic sclerosis including overlap syndromes.
